# FDA 483 - Paul R. Sieber, M.D. - October 23, 2019

Source: https://www.globalkeysolutions.net/records/483/paul-r-sieber-md/b963995a-4189-4951-88bd-84c8192ec63d

> FDA 483 for Paul R. Sieber, M.D. on October 23, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Paul R. Sieber, M.D.
- Inspection Date: 2019-10-23
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Paul R Sieber Md in Lancaster, PA, identified significant deficiencies in the management of investigational drug disposition records. The firm failed to adequately document the use and return of investigational drugs for numerous subjects, with instances of missing drug bottles and apparent back-dating of records. These findings indicate a serious lack of control over investigational drug accountability.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/kelly-n-kerr/6f9e1ba0-61ca-403d-a337-9efece792c21)

Company: https://www.globalkeysolutions.net/companies/paul-r-sieber-md/63b6e2ac-72ef-4e60-957e-f888b9757706

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8